Halozyme Therapeutics shares owned by Amundi
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Amundi
from 13F filings
Historical chart of Amundi investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Amundi consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Amundi
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $7.9M | 122k | 64.63 |
| 2025-12-31 | $1.4M | 20k | 67.30 |
| 2025-09-30 | $601k | 9.0k | 66.97 |
| 2025-06-30 | $508k | 9.4k | 53.84 |
| 2025-03-31 | $378k | 6.1k | 61.94 |
| 2024-12-31 | $342k | 6.4k | 53.76 |
| 2024-03-31 | $5.7M | 150k | 37.81 |
| 2023-12-31 | $2.0M | 58k | 34.99 |
| 2023-09-30 | $534k | 15k | 36.55 |
| 2023-06-30 | $577k | 16k | 36.88 |
| 2023-03-31 | $595k | 16k | 37.43 |
| 2022-12-31 | $803k | 16k | 50.56 |
| 2022-09-30 | $603k | 15k | 41.61 |
| 2022-06-30 | $299k | 6.3k | 47.21 |
| 2022-03-31 | $307k | 7.3k | 41.84 |
| 2021-12-31 | $316k | 8.9k | 35.46 |
| 2021-09-30 | $363k | 8.9k | 40.73 |
| 2021-06-30 | $335k | 7.4k | 45.36 |